Table 4 Mean parasite clearance times estimated from the mixed-effects model in 16 patients with severe malaria
% | All patients (95 % CI) n = 16 | Artesunate only (95 % CI) n = 12 | Artesunate and RBC exchange (95 % CI) n = 4 |
|---|---|---|---|
PCT 50 | 5.0 (4.0–6.7) | 5.0 (4.0–6.7) | 6.3 (4.6–9.7) |
PCT 75 | 10.0 (8.0–13.3) | 10.0 (8.0–13.3) | 12.6 (9.3–19.4) |
PCT 90 | 16.6 (13.3–22.1) | 16.6 (13.3–22.1) | 20.9 (15.4–32.3) |
PCT 95 | 21.6 (17.3–28.8) | 21.6 (17.3–28.8) | 27.2 (20.1–42.0) |
PCT 99 | 33.2 (26.6–44.3) | 33.2 (26.6–44.3) | 41.7 (30.9–64.5) |